DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹37,806 Cr | ₹31,580 Cr | ₹28,470 Cr | ₹25,548 Cr | ₹22,005 Cr |
What is the latest Total Liabilities ratio of DR REDDYS LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹37,806 Cr |
Mar2023 | ₹31,580 Cr |
Mar2022 | ₹28,470 Cr |
Mar2021 | ₹25,548 Cr |
Mar2020 | ₹22,005 Cr |
How is Total Liabilities of DR REDDYS LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹37,806 Cr | 19.72 | |
Mar2023 | ₹31,580 Cr | 10.92 | |
Mar2022 | ₹28,470 Cr | 11.44 | |
Mar2021 | ₹25,548 Cr | 16.10 | |
Mar2020 | ₹22,005 Cr | - |
Compare Total Liabilities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹95,946.6 Cr | -1.2% | 2.9% | -6.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹411,306.0 Cr | -2.5% | 7.6% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,343.0 Cr | -3% | 3.4% | 61.5% | Stock Analytics | |
CIPLA | ₹117,323.0 Cr | -1.6% | 3% | -3.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,619.0 Cr | -0.3% | 9% | 22.3% | Stock Analytics | |
MANKIND PHARMA | ₹99,891.5 Cr | 0.6% | 5.7% | 6.9% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -1.2% |
2.9% |
-6.4% |
SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses